Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace

Tufts' Ken Getz: Onerous Clinical Trial Protocols Contribute to High Failure Rates

Industry executives often lament the fact that clinical trials take a long time to complete and often fail. BioSpace spoke with Tufts' Ken Getz about possible reasons and solutions.

Courtesy of Tada Images/Getty Images

Merck Returns to Alzheimer’s Disease with $1.1B Cerevance Pact

Using Cerevance’s proprietary NNETSseq technology platform, Merck and Cerevance have partnered to identify new targets for the treatment of Alzheimer’s disease.

Leon Neal/Getty Images

GSK Ups Ante in ADC Discovery Game with $1.4B Mersana Option Deal

"Symptoms of a Sick Earth": Study Illuminates Impact of Climate Change on Infectious Disease

Verona, Daiichi Sankyo, AstraZeneca and Kodiak Score Big Wins in Key Diseases

More Top Stories

View all Featured Employers

What Qualities to Look for in Potential Candidates at a Career Fair

How Removing Bias From Job Descriptions is Key to Your Company's Success

Top Texas Companies Hiring Now

Courtesy of Tada Images/Getty Images

8/9/2022

Merck Returns to Alzheimer’s Disease with $1.1B Cerevance Pact

Leon Neal/Getty Images

8/9/2022

GSK Ups Ante in ADC Discovery Game with $1.4B Mersana Option Deal

8/9/2022

"Symptoms of a Sick Earth": Study Illuminates Impact of Climate Change on Infectious Disease

8/9/2022

Verona, Daiichi Sankyo, AstraZeneca and Kodiak Score Big Wins in Key Diseases

STR/NurPhoto via Getty Images

8/9/2022

Novavax Hit Hard by Late Vaccine, while BioNTech Touts Variant-Adapted Shots

View all Hotbeds

8/10/2022

Tufts' Ken Getz: Onerous Clinical Trial Protocols Contribute to High Failure Rates

Courtesy of Tada Images/Getty Images

8/9/2022

Merck Returns to Alzheimer’s Disease with $1.1B Cerevance Pact

8/9/2022

"Symptoms of a Sick Earth": Study Illuminates Impact of Climate Change on Infectious Disease

8/9/2022

Verona, Daiichi Sankyo, AstraZeneca and Kodiak Score Big Wins in Key Diseases

STR/NurPhoto via Getty Images

Novavax Hit Hard by Late Vaccine, while BioNTech Touts Variant-Adapted Shots

Cambridge Crossing, Courtesy of Marcio Jose Bastos

Biopharma Industry Shows Signs of Life in Ever-Changing Economic Landscape

Regeneron's Dupixent and Eylea Offset Drop in COVID-19 Antibody Sales

Maddie Meyer/Getty Images

Anticipating Fragmented Booster Market, Moderna Prioritizes New Product Launches

Women in Life Sciences

The Black Employee Experience

The Black Employee Experience

US Life Sciences Salary Report

Best Places to Work in Biopharma